Inventor · disambiguated record
Jordan Pober
Also filed as: POBER JORDAN · POBER JORDAN S
4 granted patents·7 pending applications·46 citations·filing 1994–2023
76Inventor score
Top patents by PatentIndex Score
11 records- 0186US6953777B2Use of interleukin-11 to prevent immune-mediated cytotoxicityUNIV YALE·Filed 2000·Granted Oct 11, 2005·20 cites·12 claims
- 0272US9081017B2Methods for identifying modulators of tumor necrosis factor receptorsBRADLEY JOHN·Filed 2006·Granted Jul 14, 2015·4 cites·12 claims
- 0370US2009191147A1Use of Interleukin-11 to Prevent Immune-Mediated CytotoxicityGENETICS INST LLC·Filed 2008·Application pending·0 cites
- 0470US2024024470A1Method of inhibiting exacerbations of t cell-mediated allograft vasculopathyALEXION PHARMA INC·Filed 2023·Application pending·0 cites
- 0552US2006062760A1Use of interleukin-11 to prevent immune-mediated cytotoxicityUNIV YALE·Filed 2005·Application pending·0 cites
- 0645US5602305AImmunodeficient animal model for studying T cell-mediated immuneUNIV YALE·Filed 1994·Granted Feb 11, 1997·16 cites·34 claims
- 0742US6001651AAntisense modulation of LFA-3ISIS PHARMACEUTICALS INC·Filed 1998·Granted Dec 14, 1999·6 cites·5 claims
- 0840US2007207125A1Vascularized human skin equivalentBOTHWELL ALFRED L·Filed 2005·Application pending·0 cites
- 0939US2018311345A1A method of inhibiting exacerbations of t cell-mediated allograft vasculopathyPOBER JORDAN·Filed 2016·Application pending·0 cites
- 1039US2004072342A1Production and use of microvessels in fibronectin-containing gelFiled 2001·Application pending·0 cites
- 1131US2018066253A1Methods and compositions for modifying endothelial cellsUNIV YALE·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →